Thorsten Oliver Goetze

5PUBLICATIONS
59CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyImmunogenetics (incl. genetic immunology)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Apr 17, 2026
Author Correction: First-line modified FOLFOX plus/minus nivolumab and Ipilimumab or FLOT plus nivolumab in advanced gastroesophageal adenocarcinoma: a phase II multi-cohort IKF-AIO-MOONLIGHT trial.

|Feb 27, 2026
First-line modified FOLFOX plus/minus nivolumab and Ipilimumab or FLOT plus nivolumab in advanced gastroesophageal adenocarcinoma: a phase II multi-cohort trial.

Sylvie Lorenzen, Thorsten Oliver Goetze, Peter C Thuss-Patience

|Oct 10, 2025
A First-in-Class mAb (BI-1607) Targeting FcγRIIB: Preclinical Data and First-in-Human Studies in Patients with HER2-Positive Advanced Solid Tumors.

Javier Cortés, Araceli Priego, Elena Garralda

|Mar 10, 2025
Neoadjuvant treatment for incidental gallbladder cancer: A systematic review.

Peeyush Varshney, Saphalta Baghmar, Bhawna Sirohi

|Jul 25, 2023
Colorectal Cancer Organoid-Stroma Biobank Allows Subtype-Specific Assessment of Individualized Therapy Responses.

Henner F Farin, Mohammed H Mosa, Benardina Ndreshkjana

Pageof 1

Frequent Collaborators

2 joint publications

Michael Bitzer

2 joint publications

Thomas Jens Ettrich

2 joint publications

Sylvie Lorenzen

1 joint publications

Peeyush Varshney